FdaApplication

NDA 204410

Back to search

Identifiers

Properties

PropertyValue
applicant_nameACTELION PHARMACEUTICALS US INC
application_typeNDA
approval_date2013-10-18

Products (1)

ProductActive ingredientStrengthDosage form
OPSUMITMACITENTAN10MGTABLET;ORAL

1 product